Abstract
Background: Breast cancer screening through mammography interpretation is crucial for early detection and improved patient outcomes. However, the manual classification of mammograms using the BIRADS (Breast Imaging-Reporting and Data System) remains challenging due to subtle imaging features, inter-reader variability, and increasing radiologist workload. Traditional computer-aided detection systems often struggle with complex feature extraction and contextual understanding of mammographic abnormalities. To address these limitations, this study proposes MammoViT, a novel hybrid deep learning framework that leverages both ResNet50's hierarchical feature extraction capabilities and Vision Transformer's ability to capture long-range dependencies in images. Methods: We implemented a multi-stage approach utilizing a pre-trained ResNet50 model for initial feature extraction from mammogram images. To address the significant class imbalance in our four-class BIRADS dataset, we applied SMOTE (Synthetic Minority Over-sampling Technique) to generate synthetic samples for minority classes. The extracted feature arrays were transformed into non-overlapping patches with positional encodings for Vision Transformer processing. The Vision Transformer employs multi-head self-attention mechanisms to capture both local and global relationships between image patches, with each attention head learning different aspects of spatial dependencies. The model was optimized using Keras Tuner and trained using 5-fold cross-validation with early stopping to prevent overfitting. Results: MammoViT achieved 97.4% accuracy in classifying mammogram images across different BIRADS categories. The model's effectiveness was validated through comprehensive evaluation metrics, including a classification report, confusion matrix, probability distribution, and comparison with existing studies. Conclusions: MammoViT effectively combines ResNet50 and Vision Transformer architectures while addressing the challenge of imbalanced medical imaging datasets. The high accuracy and robust performance demonstrate its potential as a reliable tool for supporting clinical decision-making in breast cancer screening.